Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Laurinburg › NPI 1457345597
Hospital

Scotland Memorial Hospital INC

Scotland Memorial Hospital INC was paid $39.39M by Medicaid between Jan 2018 and Dec 2024, across 179 billing codes. Its largest line is 99284, emergency room visit (serious) — 20% of everything it billed.

33Billing provider infoSCOTLAND MEMORIAL HOSPITAL INC
LAURINBURG, NC 28352
33aNPI1457345597assigned 09/06/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$39.39M
24GClaims1,017,378
24DCodes billed179
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in North Carolina

Rank by total paid#14 of 92
Median peer was paid$11.47M
This provider vs. median3.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official STONGE, LUCIEN controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018159,804$4.17M
2019144,952$4.08M
2020112,782$3.82M
2021139,453$5.65M
2022154,526$7.22M
2023148,833$7.00M
2024incomplete157,028$7.45M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 20% 56,317 51,595 $7.80M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 13% 35,313 31,559 $5.24M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 40,541 37,759 $4.74M
74177 Computed tomography, abdomen and pelvis; with contrast material 9.8% 10,989 10,015 $3.88M
J3490 Unclassified drugs 4.6% 97,860 49,199 $1.82M
70450 Computed tomography, head or brain; without contrast material 3.9% 10,918 10,026 $1.52M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2.6% 19,981 17,621 $1.02M
96361 Intravenous infusion, hydration; each additional hour 2.0% 23,343 20,207 $787K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.9% 9,358 8,611 $761K
71045 Radiologic examination, chest; single view 1.9% 34,749 31,361 $746K
96375 Therapeutic injection; each additional sequential IV push 1.9% 22,217 18,799 $734K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.8% 11,465 10,151 $708K
167 more codes
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.7% 26,045 $665K
80053 Comprehensive metabolic panel 1.5% 30,421 $587K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.5% 9,803 $575K
36415 Collection of venous blood by venipuncture 1.4% 24,196 $558K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 70,899 $470K
80048 Basic metabolic panel (calcium, ionized) 1.1% 37,052 $444K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 13,057 $359K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 26,171 $322K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 4,349 $314K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 7,805 $267K
72125 Computed tomography, cervical spine; without contrast material <1% 1,290 $258K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 5,171 $211K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,972 $206K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 15,769 $195K
81025 <1% 28,599 $193K
80076 <1% 28,257 $190K
87086 Culture, bacterial; quantitative colony count, urine <1% 17,064 $170K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 719 $162K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,275 $156K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 8,375 $154K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 2,727 $149K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 906 $143K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,868 $140K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 5,398 $135K
87428 <1% 2,262 $132K
84484 <1% 17,532 $130K
83690 <1% 21,984 $126K
81001 <1% 25,897 $115K
87070 <1% 4,250 $115K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 5,012 $114K
87400 <1% 3,604 $101K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,439 $95K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,326 $92K
81003 <1% 17,959 $84K
G0378 Hospital observation service, per hour <1% 2,383 $83K
83735 <1% 16,705 $77K
82150 <1% 14,804 $77K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 83 $70K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,231 $61K
87040 <1% 4,519 $56K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 428 $55K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 4,491 $53K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 559 $53K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 116 $46K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 275 $39K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 20,847 $38K
81015 <1% 10,739 $35K
71275 Computed tomographic angiography, chest, with contrast material <1% 267 $34K
87081 <1% 900 $30K
87077 <1% 2,349 $29K
84443 Thyroid stimulating hormone (TSH) <1% 2,835 $29K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,411 $28K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,015 $26K
71046 Radiologic examination, chest; 2 views <1% 769 $25K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 58 $25K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 692 $25K
J2270 Injection, morphine sulfate, up to 10 mg <1% 9,278 $22K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,370 $22K
96376 <1% 1,370 $22K
87220 <1% 2,886 $22K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 81 $20K
G0379 Direct admission of patient for hospital observation care <1% 185 $20K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 4,512 $19K
73630 <1% 296 $19K
J2704 Injection, propofol, 10 mg <1% 4,416 $18K
96367 <1% 55 $18K
83880 <1% 1,292 $17K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,986 $17K
87186 <1% 2,313 $14K
0240U <1% 97 $14K
87210 <1% 974 $14K
73560 <1% 265 $12K
87807 <1% 1,042 $11K
87420 <1% 284 $10K
83605 <1% 1,343 $10K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 5,257 $10K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 770 $10K
73130 <1% 164 $9K
J7120 Ringers lactate infusion, up to 1000 cc <1% 635 $9K
84702 <1% 785 $7K
59025 Fetal non-stress test <1% 140 $7K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 275 $7K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 502 $7K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 145 $7K
42830 <1% 12 $6K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 213 $6K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 342 $6K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 610 $6K
85379 <1% 890 $6K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 68 $5K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 15 $5K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 922 $4K
86900 <1% 2,107 $4K
86901 <1% 2,108 $4K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 42 $4K
73610 <1% 55 $4K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 12 $3K
J2550 Injection, promethazine hcl, up to 50 mg <1% 1,229 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 70 $3K
J7030 Infusion, normal saline solution , 1000 cc <1% 20 $3K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 137 $3K
J8597 Antiemetic drug, oral, not otherwise specified <1% 957 $3K
87590 <1% 139 $3K
95800 <1% 42 $3K
82728 <1% 185 $2K
86850 <1% 305 $2K
82550 <1% 398 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,212 $2K
93923 <1% 45 $2K
86003 <1% 17 $2K
72100 <1% 32 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 239 $2K
70551 Magnetic resonance imaging, brain; without contrast material <1% 13 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 849 $1K
83550 <1% 162 $1K
71250 <1% 13 $1K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 284 $1K
82803 <1% 184 $1K
80050 General health panel <1% 28 $1K
83540 <1% 163 $1K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 224 $1K
95816 <1% 15 $1K
88342 <1% 28 $999.74
51701 <1% 45 $992.31
77063 Screening digital breast tomosynthesis, bilateral <1% 13 $974.96
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 15 $779.46
85610 <1% 442 $734.60
99213 Doctor's office visit, returning patient (routine) <1% 52 $688.18
J7510 Prednisolone oral, per 5 mg <1% 177 $640.02
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 96 $578.27
J1644 Injection, heparin sodium, per 1000 units <1% 126 $560.15
80320 <1% 28 $458.55
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 14 $454.86
82607 <1% 32 $444.86
90715 <1% 42 $405.28
82746 <1% 30 $380.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 199 $366.45
82784 <1% 16 $310.29
85651 <1% 97 $272.07
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 139 $259.26
J1790 Injection, droperidol, up to 5 mg <1% 42 $256.08
J3535 Drug administered through a metered dose inhaler <1% 57 $232.28
85730 <1% 102 $220.19
86141 <1% 31 $212.73
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 168 $212.44
82785 <1% 15 $182.53
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 30 $178.53
S0028 Injection, famotidine, 20 mg <1% 70 $157.35
80061 Lipid panel <1% 12 $140.55
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 295 $134.03
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 98 $132.20
85027 <1% 31 $111.72
V2632 Posterior chamber intraocular lens <1% 13 $109.91
C1769 Guide wire <1% 19 $93.64
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 81 $51.33
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 377 $49.70
94761 <1% 51 $44.09
90714 <1% 38 $43.08
82272 <1% 12 $24.76
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 108 $0.59
A9270 Non-covered item or service 0% 4,124 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 19 $0.00
83036 Hemoglobin; glycosylated (A1C) 0% 14 $0.00
J7999 Compounded drug, not otherwise classified 0% 14 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 30 $0.00
77067 Screening mammography, bilateral, including computer-aided detection 0% 13 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 867 $-0.01

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSTONGE, LUCIEN (CFO)
Same official

Other billing entities under STONGE, LUCIEN

Full network →
ProviderLocationPaid
Scotland Memorial Hospital INCLaurinburg, NC$5.55M
Scotland Memorial Hospital INCPembroke, NC$3.27M
Scotland Memorial Hospital, INCLaurinburg, NC$3.04M
Scotland Memorial Hospital, INCLaurinburg, NC$1.90M
Scotland Memorial Hospital INCBennettsville, SC$1.61M
Scotland Memorial Hospital INCLaurinburg, NC$1.51M
Scotland Regional Health NetworkLaurinburg, NC$1.05M
Scotland Memorial Hospital, INCMaxton, NC$1.02M
Scotland Memorial Hospital INCLaurinburg, NC$830K
Scotland Memorial Hospital, INCWagram, NC$766K
Scotland Memorial HospitalBennettsville, SC$237K
Scotland Memorial Hospital INCLaurinburg, NC$225K
Scotland Memorial Hospital INCLaurinburg, NC$30K
Scotland Memorial Hospital, INC.Bennettsville, SC$5K
Scotland Memorial Hospital INCLaurinburg, NC$377.12

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.